Skip to content
2000
Volume 20, Issue 1
  • ISSN: 1872-2083
  • E-ISSN: 2212-4012

Abstract

Background

Trophoblast Cell Surface Antigen 2 (Trop2) is a transmembrane glycoprotein that has been implicated in the progression and metastasis of various cancers, including hepatocellular carcinoma (HCC). Targeting Trop2 expression may represent a promising approach for the development of novel therapeutic strategies and patents.

Objectives

This study aimed to investigate the effects of Trop2 knockdown using small interfering RNA (siRNA) on the phenotypic and molecular characteristics of the HepG2 liver cancer cell line.

Methods

HepG2 cells were transfected with different concentrations of Trop2-targeting siRNA (3 nM, 5 nM, and 7 nM) at various time intervals (6, 24, and 48 hrs). The expression of Trop2 was assessed by real-time PCR before and after transfection. The impact of Trop2 knockdown on cell apoptosis, migration, morphology, histopathological features, wound-healing assays, and microscopic analysis was examined. Additionally, the expression of the TPM1 gene was evaluated using immunohistochemical analysis.

Results

Trop2 mRNA level was significantly decreased in HepG2 cells in a time- and concentration-dependent manner following siRNA transfection. The downregulation of Trop2 resulted in a marked increase in apoptosis, a reduction in cell migration, and alterations in cell morphology and histopathological characteristics. Furthermore, the expression of the TPM1 gene was found to be upregulated in Trop2-knockdown HepG2 cells.

Conclusion

These results highlight the potential of Trop2 as a therapeutic target for the management of hepatocellular carcinoma.

© 2026 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/biot/10.2174/0118722083352578241225130252
2025-01-17
2025-10-21

  • From This Site

    /content/journals/biot/10.2174/0118722083352578241225130252
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. OhJ.H. JunD.W. The latest global burden of liver cancer: A past and present threat.Clin. Mol. Hepatol.202329235535710.3350/cmh.2023.0070 36891606
     [Google Scholar]
  2. RumgayH. ArnoldM. FerlayJ. Global burden of primary liver cancer in 2020 and predictions to 2040.J. Hepatol.20227761598160610.1016/j.jhep.2022.08.021 36208844
     [Google Scholar]
  3. OmarA. KasebA. ElbazT. Egyptian society of liver cancer recommendation guidelines for the management of hepatocellular carcinoma.J. Hepatocell. Carcinoma2023101547157110.2147/JHC.S404424 37744303
     [Google Scholar]
  4. YanT. YuL. ZhangN. The advanced development of molecular targeted therapy for hepatocellular carcinoma.Cancer Biol. Med.202219611610.20892/j.issn.2095‑3941.2021.0661 35699406
     [Google Scholar]
  5. SartoriusK. AntwiS.O. ChuturgoonA. RobertsL.R. KramvisA. RNA therapeutic options to manage aberrant signaling pathways in hepatocellular carcinoma: Dream or reality?Front. Oncol.20221289181210.3389/fonc.2022.891812 35600358
     [Google Scholar]
  6. AfrinH. Geetha BaiR. KumarR. AhmadS.S. AgarwalS.K. NurunnabiM. Oral delivery of RNAi for cancer therapy.Cancer Metastasis Rev.202342369972410.1007/s10555‑023‑10099‑x 36971908
     [Google Scholar]
  7. AmeriM. SalimiH. EskandariS. NezafatN. Identification of potential biomarkers in hepatocellular carcinoma: A network-based approach.Inform. Med. Unlocked20222810086410.1016/j.imu.2022.100864
     [Google Scholar]
  8. AbbasM. HeitplatzB. BernemannC. Immunohistochemical expression of TROP2 (TACSTD2) on the urothelial carcinoma of the urinary bladder and other types of cancer.Oncol. Lett.202326652710.3892/ol.2023.14114 38020299
     [Google Scholar]
  9. KoltaiT. FliegelL. The relationship between Trop2, chemotherapeutic drugs, and chemoresistance.Int. J. Mol. Sci.2023251879910.3390/ijms25010087 38203255
     [Google Scholar]
  10. LipinskiM. ParksD.R. RouseR.V. HerzenbergL.A. Human trophoblast cell-surface antigens defined by monoclonal antibodies.Proc. Natl. Acad. Sci. USA19817885147515010.1073/pnas.78.8.5147 7029529
     [Google Scholar]
  11. WenY. OuyangD. ZouQ. A literature review of the promising future of TROP2: A potential drug therapy target.Ann. Transl. Med.202210241403310.21037/atm‑22‑5976 36660684
     [Google Scholar]
  12. LombardiP. FilettiM. FalconeR. Overview of Trop2 in cancer: From pre-clinical studies to future directions in clinical settings.Cancers (Basel)20231561744176210.3390/cancers15061744 36980630
     [Google Scholar]
  13. LenártS. LenártP. ŠmardaJ. RemšíkJ. SoučekK. BenešP. Trop2: Jack of all trades, master of none.Cancers (Basel)20201211332810.3390/cancers12113328 33187148
     [Google Scholar]
  14. LiuX. LiJ. DengJ. Targeting Trop2 in solid tumors: A look into structures and novel epitopes.Front. Immunol.202314133248910.3389/fimmu.2023.1332489 38179054
     [Google Scholar]
  15. PangM-G. WangX. Le,S-S. Loss of TPM1 promotes colorectal cancer proliferation and metastasis by inducing epithelial-mesenchymal transition and regulating cytoskeletal remodeling.J. Biol. Regul. Homeost. Agents20233794691470010.23812/j.biol.regul.homeost.agents.20233709.458
     [Google Scholar]
  16. GamalN. AshrafS. HeshamN. Immunohistochemical expression of CD90, CD133, and TPM1 in relation to gastric cancer and H. pylori association.Asian Pac. J. Cancer Prev.20232462121212710.31557/APJCP.2023.24.6.2121 37378943
     [Google Scholar]
  17. ChomczynskiP. SacchiN. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.Anal. Biochem.1987162115615910.1016/0003‑2697(87)90021‑2 2440339
     [Google Scholar]
  18. RaoX. LaiD. HuangX. A new method for quantitative real-time polymerase chain reaction data analysis.J. Comput. Biol.201320970371110.1089/cmb.2012.0279 23841653
     [Google Scholar]
  19. GaoX. LeoneG.W. WangH. Cyclin D-CDK4/6 functions in cancer.Adv. Cancer Res.202014814716910.1016/bs.acr.2020.02.002 32723562
     [Google Scholar]
  20. OkashaH. HassanM. AboushoushaT. SamirS. Effect of Interferon-Beta (IFN- β) on tumor suppressor and apoptotic markers in hepatocellular carcinoma cell line.Int J Res Pharm Sci201910429362943Available from: https://ijrps.com/home/article/view/2854
    [Google Scholar]
  21. HassanM. ElzallatM. AboushoushaT. ElhussenyY. El-AhwanyE. MicroRNA-122 mimic/microRNA-221 inhibitor combination as a novel therapeutic tool against hepatocellular carcinoma.Noncoding RNA Res.20238112613410.1016/j.ncrna.2022.11.005 36474748
     [Google Scholar]
  22. KinseyE. LeeH.M. Management of hepatocellular carcinoma in 2024: The multidisciplinary paradigm in an evolving treatment landscape.Cancers (Basel)202416366610.3390/cancers16030666 38339417
     [Google Scholar]
  23. ChehelgerdiM. ChehelgerdiM. AllelaO.Q.B. Progressing nanotechnology to improve targeted cancer treatment: Overcoming hurdles in its clinical implementation.Mol. Cancer202322116910.1186/s12943‑023‑01865‑0 37814270
     [Google Scholar]
  24. LafaceC. FedeleP. MaselliF.M. Targeted therapy for hepatocellular carcinoma: Old and new opportunities.Cancers (Basel)20221416402810.3390/cancers14164028 36011021
     [Google Scholar]
  25. CorydonI.J. Fabian-JessingB.K. JakobsenT.S. 25 years of maturation: A systematic review of RNAi in the clinic.Mol. Ther. Nucleic Acids20233346948210.1016/j.omtn.2023.07.018 37583575
     [Google Scholar]
  26. LiuX. DengJ. YuanY. Advances in Trop2-targeted therapy: Novel agents and opportunities beyond breast cancer.Pharmacol. Ther.202223910829610831610.1016/j.pharmthera.2022.108296 36208791
     [Google Scholar]
  27. MasL. CrosJ. SvrcekM. Trop2 is a ubiquitous and promising target in pancreatic adenocarcinoma.Clin. Res. Hepatol. Gastroenterol.202347410210810211610.1016/j.clinre.2023.102108 36878461
     [Google Scholar]
  28. SunS. DengP. PengC. JiH. MaoL. PengL. Selenium-modified chitosan induces HepG2 cell apoptosis and differential protein analysis.Cancer Manag. Res.2022143335334510.2147/CMAR.S382546 36465707
     [Google Scholar]
  29. DanaH. ChalbataniG.M. MahmoodzadehH. Molecular mechanisms and biological functions of siRNA.Int. J. Biomed. Sci.20171324857 28824341
     [Google Scholar]
  30. WangX.D. WangQ. ChenX.L. Trop2 inhibition suppresses the proliferation and invasion of laryngeal carcinoma cells via the extracellular signal-regulated kinase/mitogen-activated protein kinase pathway.Mol. Med. Rep.201512186587010.3892/mmr.2015.3485 25779928
     [Google Scholar]
  31. SawanyawisuthK. TantapotinanN. KraiklangR. Suppression of trophoblast cell surface antigen 2 enhances proliferation and migration in liver fluke-associated cholangiocarcinoma.Ann. Hepatol.2016151718110.5604/16652681.1184223 26626643
     [Google Scholar]
  32. KiK.H. ParkD.Y. LeeS.H. KimN.Y. ChoiB.M. NohG.J. The optimal concentration of siRNA for gene silencing in primary cultured astrocytes and microglial cells of rats.Korean J. Anesthesiol.201059640341010.4097/kjae.2010.59.6.403 21253378
     [Google Scholar]
  33. ZhangJ. MaH. YangL. YangH. HeZ. Silencing of the TROP2 gene suppresses proliferation and invasion of hepatocellular carcinoma HepG2 cells.J. Int. Med. Res.20194731319132910.1177/0300060518822913 30678511
     [Google Scholar]
  34. HoangD.T. DinstagG. HermidaL.C. Prediction of cancer treatment response from histopathology images through imputed transcriptomics.Res Sq [Preprint]202313410.21203/rs.3.rs‑3193270/v137790315
     [Google Scholar]
  35. MengY. HuangK. ShiM. Research advances in the role of the tropomyosin family in cancer.Int. J. Mol. Sci.20232417132951330410.3390/ijms241713295 37686101
     [Google Scholar]
  36. HaoS WangB HouY ZhangH. Protein sHYAL-2 for inhibiting tumor development and application thereof.CN116904425A2023
/content/journals/biot/10.2174/0118722083352578241225130252
Loading
Exploring the Therapeutic Potential of TROP2 Gene Silencing in Hepatocellular Carcinoma
Recent Pat. Biotechnol. 20, 166 (2026); https://doi.org/10.2174/0118722083352578241225130252
/content/journals/biot/10.2174/0118722083352578241225130252
/content/journals/biot/10.2174/0118722083352578241225130252
Loading

Data & Media loading...


  • Article Type:     Research Article
Keyword(s): cell apoptosis; Hepatocellular carcinoma; immunohistochemical analysis; siRNA; TPM1; Trop2

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test